UniSa - IRIS Institutional Research Information System

PICILLO, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.315
EU - Europa 2.194
AS - Asia 1.985
SA - Sud America 479
OC - Oceania 68
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.063
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.245
SG - Singapore 823
CN - Cina 535
IT - Italia 513
RU - Federazione Russa 459
BR - Brasile 443
UA - Ucraina 326
IE - Irlanda 226
DE - Germania 216
TR - Turchia 153
KR - Corea 146
VN - Vietnam 146
SE - Svezia 141
HK - Hong Kong 74
EE - Estonia 69
FI - Finlandia 68
GB - Regno Unito 67
CA - Canada 47
AU - Australia 43
IN - India 39
NL - Olanda 28
NZ - Nuova Zelanda 25
CZ - Repubblica Ceca 17
AT - Austria 16
FR - Francia 14
MX - Messico 14
BD - Bangladesh 11
JP - Giappone 10
AR - Argentina 9
PL - Polonia 9
EC - Ecuador 7
IQ - Iraq 7
UZ - Uzbekistan 7
NP - Nepal 6
VE - Venezuela 6
ES - Italia 5
KE - Kenya 5
ZA - Sudafrica 5
EU - Europa 4
IL - Israele 4
MA - Marocco 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CO - Colombia 3
JM - Giamaica 3
LU - Lussemburgo 3
PK - Pakistan 3
SA - Arabia Saudita 3
BO - Bolivia 2
CL - Cile 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
ID - Indonesia 2
MK - Macedonia 2
NO - Norvegia 2
PA - Panama 2
UY - Uruguay 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
Totale 10.063
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.168
Princeton 612
Chandler 520
Wilmington 468
Jacksonville 408
Singapore 306
Houston 291
Dublin 219
Ashburn 208
Woodbridge 180
Dong Ket 144
Izmir 142
Beijing 128
Moscow 122
Andover 117
Nanjing 109
Naples 94
Boardman 82
Pellezzano 76
Hong Kong 73
Tallinn 69
Salerno 66
Norwalk 62
Dearborn 46
Düsseldorf 46
Shenyang 44
Munich 38
Fairfield 37
Redwood City 37
West Jordan 35
Mestre 34
Los Angeles 33
Changsha 32
Nanchang 32
The Dalles 30
Dallas 28
Hebei 27
Pune 25
Jiaxing 22
São Paulo 22
Rome 21
Belo Horizonte 20
Nuremberg 20
Sydney 18
Milan 16
Rio de Janeiro 16
Amsterdam 15
Brasília 15
San Diego 15
San Francisco 15
Tianjin 15
Lecce 14
Washington 14
Auckland 13
Columbus 13
Council Bluffs 12
Seattle 12
Brno 11
Guangzhou 11
New York 10
Turku 10
Curitiba 9
Lappeenranta 9
Montreal 9
Cambridge 8
Ottawa 8
Ribeirão Preto 8
Shanghai 8
Melbourne 7
Campinas 6
Carapicuíba 6
Fort Worth 6
Jinan 6
Kunming 6
Santa Clara 6
Stockholm 6
Tashkent 6
Wuhan 6
Betim 5
Bologna 5
Boston 5
Casoria 5
Dhaka 5
Fuzhou 5
Genoa 5
Guarulhos 5
Manchester 5
Nairobi 5
Napoli 5
Orange 5
Perth 5
Perugia 5
Santa Maria A Vico 5
Springfield 5
São Bernardo do Campo 5
Tokyo 5
Warsaw 5
Adelaide 4
Ankara 4
Anápolis 4
Totale 6.765
Salva come PNG Salva come JPEG
Nome #
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 156
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 132
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 128
Increased bilirubin levels in de novo Parkinson's disease 113
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 111
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 109
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 107
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 104
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 102
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 100
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 98
Gender and non motor fluctuations in Parkinson's disease: A prospective study 97
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 97
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 94
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 94
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 94
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 93
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 92
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 92
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family 89
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 89
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 88
The relevance of gender in Parkinson's disease: a review 88
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Sep;132(Pt 9):2350-5. PMID: 19584099 87
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 87
Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards 87
Quitting smoking: An early non-motor feature of Parkinson's disease? 86
Early MRI findings in acquired hepatocerebral degeneration. 85
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale 85
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 84
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 84
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 84
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 83
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 82
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family 82
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 81
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 81
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 80
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 80
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 79
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 79
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 79
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 78
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 77
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 77
Uric acid relates to dopamine transporter availability in Parkinson's disease. 76
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 76
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 75
Evolution of mild cognitive impairment in Parkinson disease 73
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 72
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 72
Non-motor correlates of smoking habits in de novo Parkinson's disease 72
Deep Brain Stimulation Target Selection for Parkinson's Disease 72
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 71
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 70
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 70
Resting brain networks in patients with Parkinson's disease and freezing of gait 69
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 69
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 68
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 68
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 67
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 67
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 65
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 64
Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects 64
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 63
Freezing of gait and executive functions in patients with Parkinson's disease. 61
Progressive Parkinsonism, Balance Difficulties, and Supranuclear Gaze Palsy 61
Recent advances in Essential Tremor: Surgical treatment 60
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 60
Progression of striatal and extrastriatal degeneration in multiple systematrophy: a longitudinal diffusion-weighted MR study 59
Teaching NeuroImages: Pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 59
Comparative neuropsychological profile of pathological gambling, hypersexuality and compulsive eating in Parkinson’s disease. 59
Dopamine receptor agonists and depression in Parkinson's disease. 58
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study 58
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 58
Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation 57
Hepatitis C virus-related hepatic myelopathy after treatment with Sofosbuvir and Ribavirin: A case report 57
Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson's disease 56
Neuropsychiatric disturbances in parkinsonian patients with and without freezing of gait 56
Midbrain MRI assessments in progressive supranuclear palsy subtypes 56
Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada 55
Subdural continuous theta burst stimulation of the motor cortex in essential tremor 55
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 55
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 54
The use of smell identification test in Parkinson's disease in Italy: Preliminary data 54
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 53
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 53
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 52
Loss of cutaneous large and small fibers in naive and l -dopa-treated PD patients 51
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 51
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 51
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 50
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 50
Exploring risk factors for stuttering development in Parkinson disease after deep brain stimulation 49
Programming Deep Brain Stimulation for Tremor and Dystonia: The Toronto Western Hospital Algorithms 48
When shaking during standing points to hereditary spastic paraplegias 48
The role of disease duration and severity on novel clinical subtypes of Parkinson disease 48
Diffusion-weighted imaging in multiple system atrophy: a comparison betweenclinical subtypes 47
Two indications, one target: Concomitant epilepsy and Tourettism treated with Centromedian/parafascicular thalamic stimulation 47
Totale 7.483
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.346
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021733 8 51 57 4 106 64 90 5 72 5 84 187
2021/2022956 11 3 6 12 11 4 18 34 132 117 138 470
2022/20231.387 183 95 70 109 180 309 16 125 189 9 72 30
2023/2024947 52 116 44 65 34 113 42 83 61 78 79 180
2024/20252.692 84 26 46 164 106 233 341 248 465 315 344 320
2025/202624 24 0 0 0 0 0 0 0 0 0 0 0
Totale 10.534